Methadone and Buprenorphine: Clinical Impact of Drug Interactions

Loading Events

« All Events

  • This event has passed.

Methadone and Buprenorphine: Clinical Impact of Drug Interactions

March 11, 2014 @ 12:00 pm - 1:00 pm

ET

Elinore McCance-Katz, MD, PhD | Chief Medical Officer, Substance Abuse and Mental Health Services Administrator

Recording unavailable at this time 

Webinar Description: 
Drug-drug interactions between opioid medications used to treat opioid use disorder, such as methadone and buprenorphine, and medications for treating co-occurring physical or mental health conditions can be a source of morbidity and mortality. This presentation will briefly review the epidemiologic data on drug-drug interactions that include methadone or buprenorphine and discuss the physiological basis for such interactions including pharmacokinetic and/or pharmacodynamics interactions. This presentation will also review drug-drug interactions and clinical consequences using a series of case studies that address questions related to issues of drug interactions in practice.

Details

Date:
March 11, 2014
Time:
12:00 pm - 1:00 pm
Event Categories:
, ,
Website:
http://www.apaeducation.org/

Other

Presenter
Elinore McCance-Katz, MD, PhD
Presenter Details
Chief Medical Officer, Substance Abuse and Mental Health Services Administrator
Time Zone
ET
Webinar Slides Link
<a href="http://psychiatry.org/File%20Library/Psychiatrists/Practice/Professional-Topics/Addiction-Psychiatry/PCSMAT/Webinar-Slides-Methadone-and-Buprenorphine-Clinical-Impact-of-Drug-Interactions.pdf" target="self">http://psychiatry.org/File%20Library/Psychiatrists/Practice/Professional-Topics/Addiction-Psychiatry/PCSMAT/Webinar-Slides-Methadone-and-Buprenorphine-Clinical-Impact-of-Drug-Interactions.pdf</a>